Statistical, population genetics and genetic epidemiology

统计、群体遗传学和遗传流行病学

基本信息

项目摘要

(1) Detecting haplotype associations This research focuses of statistical genetics problems related to association mapping. In particular, we continue to work on developing haplotype-based methods as well as other multilocus methods for detecting and characterizing genetic associations with discrete and quantitative traits. There are genetic models that lead to higher power for methods utilizing haplotype information, compared to single locus approaches. Regardless of the potential power advantages, estimation and testing of haplotypic and multilocus effects will continue to be important from the biological point of view. Some of this research is concerned with the association problem under the scenario that genetic loci are scored without the knowledge of the parental gametes, that is, when the haplotype phase is unknown. It is nevertheless possible to estimate haplotype frequencies with the corresponding effects, and this area of statistical genetics research continues to be very active. More specifically, we have been concerned with a problem of detecting haplotype associations when the important causative factors (such as environmental factors) may not have been ascertained. We considered the problem of how unknown environmental and genetic factors influence the distribution of the trait of interest among individuals that carry different classes of haplotypes or diplotypes and suggested how haplotype or diplotype-specific parameters can be adjusted to improve power under such models. These unknown factors that we consider might only influence the trait mean value, yet haplotype and diplotype-specific variances can be modified by the effect of the unknown factor. When the unknown factor is genetic, the scored (known) haplotypes can be linked to the unknown factor via linkage disequilibrium (LD), in which case we say that they are proxies for the unknown functional variation. They could also be partially functional, that is when the underlying effects are represented by joint effects of the known and the unknown factor levels. In the later case, the joint effects can be with or without interactions. In all of these cases, we find that trait variances among the observed haplotypes may be modified due to the additional factor that are unaccounted for by the analysis. Such haplotypic variance contrast between haplotypes or diplotypes can be estimated, and have been incorporated into tests for association for data with unknown haplotype phase. The approach provides additional power, especially under epistatic and heterogeneity models. A pronounced variance contrast may indicate such involvement of additional factors that influence the trait. Any given population can assume joint frequencies (of the known and the unknown factors) that could result in the marginal effect at the observed locus to be either negative, or positive, or anywhere half-way, that is close to zero. Consequently, the power to detect an association can be small and unpredictable. One can express a population measure of association, such as the relative risk, in terms of the joint effects and their frequencies and solve for frequency configurations that result in the absence of effect at the observed locus. We found however, that a variety of genetic models, particularly those that involve an interaction between A and B, result in a substantial variance contrast at the alleles (haplotypes) of the observed locus. If sample is taken from a population with such frequencies that the marginal effect at the observed locus is small, incorporating the variance parameters into a test can improve power to detect association. One can start with testing the mean and the variance contrasts simultaneously, then proceed with the mean- and the variance-specific tests. A substantial variance contrast might be considered as an indication of an involvement of important factors unaccounted for by the study. We proposed and compared several variations of these tests within the likelihood ratio framework. The tests included into comparisons differed in several respects (i) the variances can be estimated in different ways, and allowed to be the same or different while comparing the means; (ii) the overall test that includes all haplotypes can be based on summing up contributions across haplotypes, alternatively, the overall statistic value can be driven by haplotypes with the largest contributions; (iii) the models of analysis can be haplotype, or diplotype-based, with diplotype-based variations allowing for co-dominant, dominant and recessive modes of analysis. (2) Composite linkage disequilibrium correlation for multiple alleles. Several earlier studies found good performance and robustness of the composite LD measures. Schaid (2004) extended the composite LD testing to the case of multiple alleles, while explicitly incorporating Hardy-Weinberg equilibrium (HWE) deviations into the variance of the test statistic. An earlier method by Weir (Biometrics 1979) was based on a sum of the composite squared correlation LD coefficients, however it is desirable to find an approximate distribution for a similar statistic that would include HWE deviations explicitly into the sum and work for multiple alleles. This year, we published two chi-square approximations, one based on eigenvalues of the variance-covariance matrix of the composite LD coefficients, and the second, much simpler chi-square approximation for a statistic that adds (non-independent) squared LD coefficients across all pairs of alleles, while still incorporating HWE deviations into the variance. We performed extensive comparisons showing good statistical properties of these approximations. For the case of the known haplotype phase, the new test has high power as a test for homogeneity of multinomial samples (e.g. samples of alleles or genotypes) obtained from several populations. The power is found to be higher than that of the traditional approaches under models of association between rows and columns where association is spread out among multiple cells.
(1)检测单倍型关联

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Use of pairwise marker combination and recursive partitioning in a pharmacogenetic genome-wide scan.
在药物遗传学全基因组扫描中使用成对标记组合和递归分区。
  • DOI:
    10.1038/sj.tpj.6500414
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Warren,LL;Hughes,AR;Lai,EH;Zaykin,DV;Haneline,SA;Bansal,AT;Wooster,AW;Spreen,WR;Hernandez,JE;Scott,TR;Roses,AD;Mosteller,M;CNA30027andCNA30032studyteams
  • 通讯作者:
    CNA30027andCNA30032studyteams
Large recursive partitioning analysis of complex disease pharmacogenetic studies. II. Statistical considerations.
复杂疾病药物遗传学研究的大型递归分区分析。
  • DOI:
    10.1517/14622416.6.1.77
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Zaykin,DmitriV;Young,SStanley
  • 通讯作者:
    Young,SStanley
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

dmitri v zaykin其他文献

dmitri v zaykin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('dmitri v zaykin', 18)}}的其他基金

Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    10260280
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    7968195
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    8929785
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiolog
统计、群体遗传学和遗传流行病学
  • 批准号:
    7330690
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    8553776
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    10007476
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    8336629
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical population genetics and genetic epidemiology
统计群体遗传学和遗传流行病学
  • 批准号:
    7174899
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    8734143
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:
Statistical, population genetics and genetic epidemiology
统计、群体遗传学和遗传流行病学
  • 批准号:
    9143481
  • 财政年份:
  • 资助金额:
    $ 36.11万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 36.11万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 36.11万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 36.11万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 36.11万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 36.11万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 36.11万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 36.11万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 36.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 36.11万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 36.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了